To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

In addition to its health impact on patients, PAH leads to high payer-paid medical and pharmacy costs, as well as high out-of-pocket costs. 6 According to a study of commercial insurance and Medicare ...

Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...

The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...

Death is 'a reality we must face', wrote Pope Francis in a homily released during his hospitalization at Gemelli. 'It is a ...

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

Abdominal aortic aneurysm (AAA) repair has undergone a remarkable transformation over the last 2 decades, primarily driven by ...

Researchers at the University of California San Diego School of Medicine have identified a potential new treatment, an ...

Advances in hypertension as reported at ACC 2025 include two new therapies that achieve significant blood pressure (BP) ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment ... resistant hypertension, although the two companies are still partnered on a follow-up use in pulmonary ...

If a picture is worth a thousand words, how much is a graph worth? For doctors trying to determine whether a patient's blood ...

Nov. 21, 2024 — Scientists have discovered how long-term treatment ... the Risk of Hypertension in Adolescents Nov. 11, 2024 — Adolescents who meet the recommended guidelines of nine to ...